DPA
TECH icon

Delphi Private Advisors’s Bio-Techne TECH Stock Holding History

Delphi Private Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-52
Closed -$1K – 430
2016
Q3 		$1K Hold
52
– – ﹤0.01% 402
2016
Q2 		$1K Buy
+52
New +$1.34K ﹤0.01% 419

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Delphi Private Advisors's TECH Position: Q4 2016 in Review

Delphi Private Advisors sold out of Bio-Techne (TECH) in Q4 2016, closing a stake of 52 shares — an estimated $1K sold.

Delphi Private Advisors first reported a position in TECH in Q2 2016 and held it in 2 quarters. The position peaked at $1K in Q3 2016. 281 funds tracked by Wall St. Rank hold TECH as of Q4 2016.

  • Delphi Private Advisors reported no remaining Bio-Techne position as of Q4 2016 after selling out during the quarter.
  • Delphi Private Advisors sold 52 Bio-Techne shares in Q4 2016, an estimated $1K.
  • Delphi Private Advisors first reported a position in Bio-Techne in Q2 2016 and held it in 2 quarters.
  • Delphi Private Advisors's Bio-Techne position peaked at $1K in Q3 2016.
  • 281 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2016.

Based on Delphi Private Advisors's 13F filing for Q4 2016, filed 31 Jan 2017.